Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Meningioma 1 Glioblastoma 1 Frailty 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Lung Neuroendocrine Tumor 1

Interventions

epigallocatechin gallate 2 Ascorbic Acid 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 cabozantinib 1 Temozolomide 1 Quercetin 1 Protons 1 Photons 1 Flavonoids 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × Photons × Clear all

NCT05548504 2022-09-21

HERAN2

Odense University Hospital

Phase 2 Not yet recruiting

Frailty, Carcinoma, Non-Small-Cell Lung, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡